# Levodopa Concentration Profile With Stalevo 75/125 mg

> **NCT01070628** · PHASE1 · COMPLETED · sponsor: **Orion Corporation, Orion Pharma** · enrollment: 20 (estimated)

## Conditions studied

- Parkinson's Disease

## Interventions

- **DRUG:** Stalevo (levodopa/ carbidopa/ entacapone)
- **DRUG:** Sinemet (levodopa/carbidopa)

## Key facts

- **NCT ID:** NCT01070628
- **Lead sponsor:** Orion Corporation, Orion Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-12
- **Primary completion:** 2010-02
- **Final completion:** 2010-02
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2010-08-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01070628

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01070628, "Levodopa Concentration Profile With Stalevo 75/125 mg". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01070628. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*